Neuromuscular Disorder Articles & Analysis
6 news found
MVP is MDA’s drug development program, which is exclusively focused on funding the discovery and clinical application of treatments and cures for neuromuscular disorders. MVP evaluates and makes targeted investments in for-profit and not-for-profit companies and academics developing therapeutics. ...
BynVector
“Pompe disease is a progressive, life-limiting neuromuscular disorder caused by the accumulation of lysosomal glycogen in cardiac and skeletal muscle as well as the CNS. ...
Medis will commercialize NaMuscla® for the symptomatic treatment of myotonia in adults with non-dystrophic myotonic (NDM) disorders in Central and Eastern European countries.NaMuscla® is the first and only licensed product for this indication. NDM disorders are a group of rare, inherited neuromuscular disorders which is ...
atai Life Sciences ("atai" or the "Company"), a global biopharmaceutical company developing psychedelic and non-psychedelic compounds for various mental health indications, has acquired a majority stake in Delaware based Psyber, a company dedicated to developing interventions to improve various mental health disorders and induce behavioural changes through brain computer ...
The main objectives were to evaluate the safety and the immunogenicity after 3 subcutaneous injections with the CV-MG01 vaccine Population of subjects: The therapeutic vaccine (or placebo) was tested on 24 patients with Myasthenia Gravis, a chronic autoimmune neuromuscular disorder (mean age: 42 years, 24 – 64 years; 18 females, 6 males) with low to ...
Grip strength is a widely used measure of mouse limb strength, employed to investigate the effects of drugs and neuromuscular disorders. Finally, the investigators looked at the effects of triclosan exposure on fathead minnows, a small fish commonly used as a model organism for studying the potential impacts of aquatic pollutants. ...